Edwards Lifesciences (EW) down despite profit rise
Posted on February 05, 2013 at 01:50 AM EST
Edwards Lifesciences Corp. (NYSE: EW) shares slid 6.2% to $87.29. The medical devices company on Monday reported its fourth-quarter profit rose 44% but projected first-quarter earnings of 74 cents to 78 cents a share compared with analysts’ estimate of 77 cents a share. Share volume was 285,000, beating an all-day average of 200,000